Cargando…
Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30
PURPOSE: Physical functioning and fatigue are key patient concerns in myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). The objective of this research was to generate supportive quantitative evidence for modular physical functioning and fatigu...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292469/ https://www.ncbi.nlm.nih.gov/pubmed/34283303 http://dx.doi.org/10.1186/s41687-021-00334-w |
_version_ | 1783724836919443456 |
---|---|
author | Regnault, Antoine Pompilus, Farrah Ciesluk, Anna Mazerolle, Flora Bejar, Rafael Fram, Robert J. Faller, Douglas V. Marquis, Patrick Bell, Jill A. |
author_facet | Regnault, Antoine Pompilus, Farrah Ciesluk, Anna Mazerolle, Flora Bejar, Rafael Fram, Robert J. Faller, Douglas V. Marquis, Patrick Bell, Jill A. |
author_sort | Regnault, Antoine |
collection | PubMed |
description | PURPOSE: Physical functioning and fatigue are key patient concerns in myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). The objective of this research was to generate supportive quantitative evidence for modular physical functioning and fatigue measures based on the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 items (QLQ-C30) and a customized selection of 10 supplemental items from the EORTC Item Library. METHODS: The 40 items were completed online cross-sectionally by 51 patients (higher risk [HR] MDS: 53%; CMML: 26%; AML: 10%). Psychometric analyses based on Rasch measurement theory (RMT) were conducted on the QLQ-C30 physical functioning and fatigue domains as well as measures combining QLQ-C30 and supplemental items. A measure of anemia-related symptoms composed of QLQ-C30 and supplemental items covering fatigue, dyspnea, and dizziness was also investigated. RESULTS: The QLQ-C30 physical functioning and fatigue domains showed good targeting to the sample and adequate reliability, with few conceptual gaps identified. Combining the QLQ-C30 and supplemental physical functioning and fatigue items improved the conceptual coverage and the reliability of the measures. The patient-reported anemia-related symptom measure showed good measurement performance, underpinned by a clinically meaningful characterization of severity of these symptoms over a spectrum, starting with fatigue, then dyspnea, and finally dizziness (most severe). CONCLUSION: The modular measurement approach of combining EORTC QLQ-C30 and Item Library offers a promising pragmatic solution to the measurement of physical functioning and fatigue, as well as anemia-related symptoms in clinical trials conducted in HR MDS, CMML, and AML. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-021-00334-w. |
format | Online Article Text |
id | pubmed-8292469 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-82924692021-08-05 Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30 Regnault, Antoine Pompilus, Farrah Ciesluk, Anna Mazerolle, Flora Bejar, Rafael Fram, Robert J. Faller, Douglas V. Marquis, Patrick Bell, Jill A. J Patient Rep Outcomes Research PURPOSE: Physical functioning and fatigue are key patient concerns in myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). The objective of this research was to generate supportive quantitative evidence for modular physical functioning and fatigue measures based on the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 items (QLQ-C30) and a customized selection of 10 supplemental items from the EORTC Item Library. METHODS: The 40 items were completed online cross-sectionally by 51 patients (higher risk [HR] MDS: 53%; CMML: 26%; AML: 10%). Psychometric analyses based on Rasch measurement theory (RMT) were conducted on the QLQ-C30 physical functioning and fatigue domains as well as measures combining QLQ-C30 and supplemental items. A measure of anemia-related symptoms composed of QLQ-C30 and supplemental items covering fatigue, dyspnea, and dizziness was also investigated. RESULTS: The QLQ-C30 physical functioning and fatigue domains showed good targeting to the sample and adequate reliability, with few conceptual gaps identified. Combining the QLQ-C30 and supplemental physical functioning and fatigue items improved the conceptual coverage and the reliability of the measures. The patient-reported anemia-related symptom measure showed good measurement performance, underpinned by a clinically meaningful characterization of severity of these symptoms over a spectrum, starting with fatigue, then dyspnea, and finally dizziness (most severe). CONCLUSION: The modular measurement approach of combining EORTC QLQ-C30 and Item Library offers a promising pragmatic solution to the measurement of physical functioning and fatigue, as well as anemia-related symptoms in clinical trials conducted in HR MDS, CMML, and AML. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-021-00334-w. Springer International Publishing 2021-07-20 /pmc/articles/PMC8292469/ /pubmed/34283303 http://dx.doi.org/10.1186/s41687-021-00334-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Regnault, Antoine Pompilus, Farrah Ciesluk, Anna Mazerolle, Flora Bejar, Rafael Fram, Robert J. Faller, Douglas V. Marquis, Patrick Bell, Jill A. Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30 |
title | Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30 |
title_full | Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30 |
title_fullStr | Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30 |
title_full_unstemmed | Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30 |
title_short | Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30 |
title_sort | measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on eortc qlq-c30 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292469/ https://www.ncbi.nlm.nih.gov/pubmed/34283303 http://dx.doi.org/10.1186/s41687-021-00334-w |
work_keys_str_mv | AT regnaultantoine measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30 AT pompilusfarrah measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30 AT cieslukanna measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30 AT mazerolleflora measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30 AT bejarrafael measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30 AT framrobertj measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30 AT fallerdouglasv measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30 AT marquispatrick measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30 AT belljilla measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30 |